Applied DNA (NASDAQ:APDN) stock is rocketing higher on Tuesday after the company revealed its starting analytical validation of a monkeypox virus test.
The new test from Applied DNA has been developed as a New York State Department of Health (NYSDOH) Laboratory Developed Test. If the current validation goes well, the company intends to submit it to NYSDOH for approval.
Read more about APDN stock here.
The post Why Is Applied DNA (APDN) Stock Up 212% Today? appeared first on InvestorPlace.